Upadacitinib versus Placebo or Adalimumab in Patients with Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase 3, Double-Blind, Randomized Controlled Trial
Arthritis Rheumatol 2019 DOI: 10.1002/art.41032
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Arthritis Rheumatol 2019 DOI: 10.1002/art.41032
Rheumatology (Oxford). DOI: 10.1093/rheumatology/kez087
Arthritis Res Ther. 2019 Apr 5;21(1):89.
Mod Rheumatol. 2019 Feb 20:1-23. DOI: 10.1080/14397595.2019.1583711
Arthritis Rheumatol. 2019 Jun;71(6):878-891
Semin Arthritis Rheum. 2018 Dec;48(3):406-415. doi: 10.1016/j.semarthrit.2018.07.006.
Lancet 2018 Dec 1;392(10162):2378-2387. DOI 10.1016/S0140-6736(18)32463-2
Lancet. 2018 Dec 1;392(10162):2367-2377. DOI 10.1016/ S0140-6736(18)32483-8
Z Rheumatol. 2018 Sep 6. DOI 10.1007/s00393-018-0531-5
J Rheumatol. 2019 Jan;46(1):7-18. DOI: 10.3899/jrheum.171361